Anavex Life Sciences Corp (AVXL)

[JB3729]

I do think we'll get data sooner than the end of the year. Originally, Missling stated that top line results would be reported in September. He didn't say partial top line results, so, I figure he meant for all 32 of the patients.

It's possible that the trial has backed up a little and he won't have the remainder of the top line results until October.

Then we can expect the full Phase 2A Part A results at the end of the year.

My wag.